BILL ANALYSIS

Senate Research Center	H.B. 220
89R22703 MCF-F	By: Ordaz et al. (Huffman)
	State Affairs
	5/23/2025
	Engrossed

AUTHOR'S / SPONSOR'S STATEMENT OF INTENT

H.B. 220 requires health care facilities treating sexual assault survivors to offer an FDA-approved emergency contraceptive to prevent pregnancy by delaying ovulation, provided the survivor consents and the treatment is clinically indicated. The bill also clarifies that such facilities may not provide or offer any drug or device intended to terminate a pregnancy. 

H.B. 220 amends current law relating to the care provided to sexual assault survivors by health care facilities.

RULEMAKING AUTHORITY

This bill does not expressly grant any additional rulemaking authority to a state officer, institution, or agency.

SECTION BY SECTION ANALYSIS

SECTION 1. Amends Section 323.004, Health and Safety Code, by amending Subsection (b) and adding Subsection (b-2), as follows:

(b) Requires a health care facility providing care to a sexual assault survivor to provide the survivor with certain remedies and information, including, if the survivor consents and the treatment is clinically indicated, an emergency contraceptive approved by the United States Food and Drug Administration to prevent pregnancy by delaying ovulation. Makes nonsubstantive changes.

(b-2) Prohibits a health care facility providing care to a sexual assault survivor from providing or offering to provide the survivor with a drug or device that terminates a pregnancy.

SECTION 2. Effective date: September 1, 2025.